Millipore Sigma Vibrant Logo

579000 Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem

Tamoxifen is a potent synthetic anti-estrogenic agent.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: Estrogen Receptor Signaling Regulator I

Primary Target: PKC
View Products on Sigmaaldrich.com
579000
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
54965-24-1C₂₆H₂₉NO · C₆H₈O₇

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
579000-100MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 100 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA potent synthetic anti-estrogenic agent. A cell-permeable and reversible inhibitor of protein kinase C (IC50 = 10 µM). Induces apoptosis in human malignant glioma cell lines and inhibits prostate cancer cell growth by induction of p21 protein.
      Catalogue Number579000
      Brand Family Calbiochem®
      SynonymsEstrogen Receptor Signaling Regulator I
      References
      ReferencesRohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.
      Product Information
      CAS number54965-24-1
      ATP CompetitiveN
      FormWhite to off-white powder
      Hill FormulaC₂₆H₂₉NO · C₆H₈O₇
      Chemical formulaC₂₆H₂₉NO · C₆H₈O₇
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKC
      Primary Target IC<sub>50</sub>10 µM against protein kinase C
      Purity≥99% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKH2387000
      Safety Information
      R PhraseR: 22-45-60-61-64

      Harmful if swallowed.
      May cause cancer.
      May impair fertility.
      May cause harm to the unborn child.
      May cause harm to breastfed babies.
      S PhraseS: 36/37/39-45

      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      579000-100MG 04055977265934

      Documentation

      Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      579000

      Riferimenti bibliografici

      Panoramica delle referenze
      Rohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.

      Brochure

      Titolo
      Caspases and other Apoptosis Related Tools Brochure
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-January-2010 RFH
      SynonymsEstrogen Receptor Signaling Regulator I
      DescriptionA potent synthetic anti-estrogen. A cell-permeable and reversible inhibitor of protein kinase C (IC50 = 10 µM). Induces apoptosis in human malignant glioma cell lines.
      FormWhite to off-white powder
      CAS number54965-24-1
      RTECSKH2387000
      Chemical formulaC₂₆H₂₉NO · C₆H₈O₇
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityEthanol (5 mg/ml), Methanol (5 mg/ml), or sparingly soluble in H₂O
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 9048
      ReferencesRohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.